Abstract
Presentation Description :
This presentation consolidates findings from two investigative studies, underscoring the pivotal role of Virtual Reality (VR) in evaluating and developing innovative clinical endpoints for inherited retinal diseases, with a focus on retinitis pigmentosa (RP). Initially, we delve into a novel mobility test, which, through meticulous validation in both real and virtual environments, demonstrates paramount reproducibility and reliability. Subsequently, the discussion pivots to a study concerning a VR-based visual search task, conducted with the same population. Collectively, these studies fortify VR’s potential in devising novel clinical endpoints within ophthalmology.
This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.